Research ArticleOpen AccessGoogle Scholar indexed
Synthesis, Structure Analysis and Antibacterial Activity of New Potent Sulfonamide Derivatives
- 1
- 2
- 3
- 4
Journal of Biomaterials and Nanobiotechnology·Volume 02 (2011)·Pages 143–148·Published 29 April 2011·DOI10.4236/jbnb.2011.22018
Copy link · social · email
Abstract
Modification of sulfonamid drug using different principles of chemical reactions was investigated. These reactions involve the condensation of an amino group with triethyl orthoformate and dimethylformamide dimethyl acetal. Ability of sulfa to condense with active keto compounds, like ethyl pyruvate and piprazine carboxyaldehye was studied. Alkyation of sulfa with different chloro derivatives was also reported. The structure of the isolated compound was elucidated and confirmed using elemental analysis and spectral data. The bioactivity of the ob-tained compounds was investigated against different gram positive and gram negative bacteria. The study reveals that most of the modified drugs show high to moderate antibacterial activity.
KeywordsSulfonamideSulfa drugGram positiveGram negative bacteria
- [1] N. Hen, M. Bialer, B. Wlodarczyk, R. H. Finnell and B. Yagen, “Syntheses and Evaluation of Anticonvulsant Pro-file and Teratogenicity of Novel Amide Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenz- ene sulfonamide,” Journal Medical Chemistry, Vol. 53, No. 10, 2010, pp. 4177-4186. doi:10.1021/jm100170w
- [2] F.Carta, A. Maresca, A. Scozzafava, D. Vullo and C. T. Supuran, “Carbonic Anhydrase Inhibitors. Diazenylben-zenesulfonamides are Potent and Selective Inhibitors of the Tumor-Associated Isozymes IX and XII over the Cytosolic Isoforms I and II,” Bioorganic & Medical Chemistry, 2009, Vol. 17, No.20, 7093-7099. doi:10.1016/j.bmc.2009.09.003
- [3] K. Namba, X. Zheng, K. Motoshima, H. Kobayashi, A. Tai, E. Takahashi, K. Sasaki, K. Okamoto and H. Kakuta, “De-sign and Synthesis of Benzenesulfonanilides Active against Methicillin-Resistant Staphylococcus Aureus and Vanco-mycin-Resistant,” Enterococcus Bioorganic & Medical Chemistry, Vol. 16, No. 11, 2008, pp. 6131-6144.
- [4] P. Joseph, F. Turtaut, S. Ouahrani-Bettache, J. L. Montero, I. Nishimori, T. Minakuchi, D. Vullo, A. Scozzafava, S. Kohler, J.-Y. Winum and C. T. Supuran. “Cloning, Char-acterization, and Inhibition Studies of a β-Carbonic Anhy-drase from Brucella suis,” Journal Medical Chemistry, 2010, Vol. 53, No. 5, pp 2277-2285. doi:10.1021/jm901855h
- [5] B. L. Wilkinson, L. F. Bornaghi, A. D. Wright, T. A. Houston and S. A. Poulsen, “Anti-Mycobacterial Activity of a Bis-Sulfonamide,” Bioorganic & Medical Chemistry Letter, Vol. 17, No. 5, 2007, pp. 1355-1357. doi:10.1016/j.bmcl.2006.11.079
- [6] B. G. Katzung, Basic and Clinical Pharma cology, 6th ed.; University of California: San Francisco, 1995.
- [7] S. Joshi and N. Khosla, “QSAR Study on Anti Bacterial Activity of Sulfonamides and Derived Mannich Bases,” Bioorganic Medical Chemistry Letter, Vol. 13, No. 21, 2003, pp. 3747-3751. doi:10.1016/j.bmcl.2003.08.017
- [8] S. Joshi, N. Khosla and P. Tiwari, “In Vitro Study of Some Medicinally Important Mannich Bases Derived from an An-titubercular Agent,” Bioorganic & Medical Chemistry, Vol. 12, No. 3, 2004, pp. 571-576. doi:10.1016/j.bmc.2003.11.001
- [9] N. Anand, “Sulfonamides and Sulfones. In Burger’s Me-dicinal Chemistry and Drug Discovery,” New York, 1996, pp. 527-573.
- [10] A. Kamal, M. N. A. Khan, K. S. Reddy, K. Rohini, G. N. Sastry, B. Sateesh and B. Sridhar, “Synthesis, Structure Analysis and Antibacterial Activity of Some Novel 10-Substituted 2-(4-Piperidyl/Phenyl) -5, 5-Dioxo [1,2,4] triazolo [1,5b] [1,2,4] Benzothiadiazine Derivatives,” Bio-organic & Medical Chemistry Letter, Vol. 17, 2007, pp. 5400-5405. doi:10.1016/j.bmcl.2007.07.043